Genevec Contra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Genevec Contra and buy or sell other stocks, ETFs, and their options commission-free!About GNVC
GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform.
CEODouglas J. Swirsky, MBA, CPA
CEODouglas J. Swirsky, MBA, CPA
Employees—
Employees—
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded1992
Founded1992
Employees—
Employees—
GNVC Key Statistics
Market cap16.36M
Market cap16.36M
Price-Earnings ratio-1.97
Price-Earnings ratio-1.97
Dividend yield—
Dividend yield—
Average volume8.00K
Average volume8.00K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.44
52 Week high$10.44
52 Week low$2.70
52 Week low$2.70
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.